Compliance Rate
Compliance Rate
36.36%
Compliant submissions
8
Incompliant submissions
14
Total trials
22
My Organizations' Clinical Trials
Showing 950 of 1641 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/01
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 07/05/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 05/20/22
End: 08/20/22
Due: 08/20/23
Phase: N/A
Priority: Normal
Start: 02/27/22
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 10/15/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 05/31/25
Due: 05/31/26
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 02/22/24
End: 09/30/29
Due: 09/30/30
Phase: N/A
Priority: Normal
Start: 08/04/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 04/06/21
End: 10/04/24
Due: 10/04/25
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 10/10/21
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 10/13/17
End: 09/06/19
Due: 09/06/20
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 07/16/24
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 05/01/15
End: 11/14/22
Due: 11/14/23
Phase: N/A
Priority: Normal
Start: 05/13/17
End: 10/10/20
Due: 10/10/21
Phase: N/A
Priority: Normal
Start: 01/16/25
End: 01/31/30
Due: 01/31/31
Phase: N/A
Priority: Normal
Start: 05/31/24
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 11/01/20
End: 02/02/22
Due: 02/02/23
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 07/21/16
End: 03/30/21
Due: 03/30/22